The efficacy and safety of tofacitinib in Asian patients with moderate to severe chronic plaque psoriasis: A Phase 3, randomized, double-blind, placebo-controlled study - Zhang, J; Tsai, T-F; Lee, M-G (J Dermatol Sci, 2017)
et al.